SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-088596
Filing Date
2023-08-08
Accepted
2023-08-08 07:20:54
Documents
14
Period of Report
2023-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323012d4_8k.htm   iXBRL 8-K 37426
2 EXHIBIT 10.1 tm2323012d4_ex10-1.htm EX-10.1 80254
  Complete submission text file 0001104659-23-088596.txt   353150

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20230808.xsd EX-101.SCH 3257
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20230808_def.xml EX-101.DEF 26188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20230808_lab.xml EX-101.LAB 35952
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20230808_pre.xml EX-101.PRE 24846
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323012d4_8k_htm.xml XML 4312
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 231149317
SIC: 2836 Biological Products, (No Diagnostic Substances)